For citations:
Simanenkova A.V., Fuks O.S., Timkina N.V., Sufieva D.A., Kirik O.V., Korzhevskii D.E., Vlasov T.D., Karonova T.L. Highly selective sodium-glucose co-transporter type 2 inhibitor empagliflozin as means of brain protection in conditions of chronic brain dyscirculation. Problems of Endocrinology. 2024;70(4):44-56. (In Russ.) https://doi.org/10.14341/probl13336

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).